By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



39, rue du Bois Chaland

Evry Cedex    91029  France
Phone: 33-1-608-72600 Fax: 33-1-608-61609



Company News
Ipsen (IPN.PA) Joins National Pharmaceutical Council 3/28/2017 11:53:37 AM
Ipsen (IPN.PA) Release: Blazing New Trails: Updates In The Care Of Children With Cerebral Palsy 3/21/2017 6:35:24 AM
Ipsen (IPN.PA) Announces Health Canada Approval Of DYSPORT THERAPEUTIC (Abobotulinumtoxina) For The Treatment Of Patients With Cervical Dystonia And Adult Upper Limb Spasticity 3/14/2017 8:56:33 AM
Ipsen (IPN.PA) Announces MHRA1 Approval Of New Indication For Decapeptyl For The Treatment Of Pre-Menopausal Women With Early Stage Breast Cancer 3/13/2017 6:23:28 AM
Ipsen (IPN.PA) Announces Data Presentations Of Lanreotide (Somatuline Autogel), Telotristat Ethyl And The Investigational Compound 177Lu-OPS201 At The European Neuroendocrine Tumor Society (ENETS) 2017 Conference 3/9/2017 6:30:47 AM
Ipsen (IPN.PA) Appoints Benoit Hennion As Executive Vice President And President, Primary Care 3/2/2017 7:55:55 AM
Ipsen (IPN.PA) Delivers Strong 2016 Results And Expects Further Sales Growth And Margin Enhancement For 2017 2/23/2017 7:02:35 AM
Ipsen (IPN.PA) Agrees to Hire 100 Merrimack (MACK) Employees Under $575 Million Cancer Deal 2/15/2017 6:58:00 AM
Sanofi (SNY) Unloads Five OTC Drugs to Ipsen (IPN.PA) for $88 Million to Pave Way for Boehringer Ingelheim Deal 2/13/2017 5:55:35 AM
Ipsen (IPN.PA) To Acquire Primary Care Platform In Italy From Akkadeas Pharma 1/31/2017 11:17:43 AM